Skip to main content
Livermore
Livermore
ZHEN

Clarius Group, LLC

SEC CIK
0001664214
Latest filing
Jan 14, 2026

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Clarius Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overviewAll 13F holders of RXRXFull Q4 2025 holdings

Shares (Q4 2025)
28,601
Value
$117.0K
% of portfolio
<0.1%
Quarters held
17
Since Q4 2021
Holdings of RXRX by Clarius Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202528,601$117.0K<0.1%00.0%UnchangedHolders
Q3 202528,601$139.6K<0.1%00.0%UnchangedHolders
Q2 202528,601$144.7K<0.1%00.0%UnchangedHolders
Q1 202528,601$151.3K<0.1%00.0%UnchangedHolders
Q4 202428,601$193.3K<0.1%00.0%UnchangedHolders
Q3 202428,601$188.5K<0.1%00.0%UnchangedHolders
Q2 202428,601$214.5K<0.1%00.0%UnchangedHolders
Q1 202428,601$285.2K<0.1%00.0%UnchangedHolders
Q4 202328,601$282.0K<0.1%00.0%UnchangedHolders
Q3 202328,601$218.8K<0.1%00.0%UnchangedHolders
Q2 202328,601$213.6K<0.1%00.0%UnchangedHolders
Q1 202328,601$190.8K<0.1%00.0%UnchangedHolders
Q4 202228,601$221.0K<0.1%00.0%UnchangedHolders
Q3 202228,601$304.0K<0.1%00.0%UnchangedHolders
Q2 202228,601$233.0K<0.1%+15,001+110.3%AddedHolders
Q1 202213,600$233.0K<0.1%00.0%UnchangedHolders
Q4 202113,600$233.0K<0.1%+13,600NewHolders